|
|
News Breaks
|
October 27, 2009
|
| 07:49 EDT |  | ONCY |
| theflyonthewall.com: | Oncolytics Biotech announces issuance of 33rd U.S. patent | | Oncolytics Biotech Inc. announced that it has been granted its 33rd U.S. Patent, # 7,608,257, entitled "Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells With a Virus." The patent claims cover methods of using reovirus in combination with currently approved chemotherapeutic agents to treat patients that are refractory to those chemotherapeutic agents alone. "This patent supports our expanding clinical program, including our first Phase III study, looking at REOLYSIN in combination with a range of chemotherapeutic agents," said Mary Ann Dillahunty, Vice President of Intellectual Property for Oncolytics. :theflyonthewall.com |
|
|
News For ONCY From The Last 14 Days Check below for free stories on ONCY the last two weeks.
| Sign up for a free trial to see the rest of the stories you've been missing. |
There are no results for these search parameters.
|
|
|
|
